The Department commissioned ORC International to conduct a quantitative research study to obtain a quantitative baseline measure of awareness, knowledge and intentions around biosimilar medicines. The outcomes of this research have informed the development of communication strategies and educational materials for the Biosimilar Awareness Initiative. The key target audiences for the research were:
- Specialists who are potential prescribers of biological and biosimilar medicines;
- General practitioners who are potential prescribers of biological and biosimilar medicines;
- Community pharmacists who are potential dispensers of biological and biosimilar medicines and advisors to patients; and
- Patients with associated conditions and their carers.
You can access a copy of the Research report:
Research Report (PDF 2521 KB)
Research Report (Word 3036 KB)